Molecular basis of functional myogenic specification ofBona Fidemultipotent adult cardiac stem cells
- 18 April 2018
- journal article
- review article
- Published by Taylor & Francis Ltd in Cell Cycle
- Vol. 17 (8), 927-946
- https://doi.org/10.1080/15384101.2018.1464852
Abstract
Ischemic Heart Disease (IHD) remains the developed world's number one killer. The improved survival from Acute Myocardial Infarction (AMI) and the progressive aging of western population brought to an increased incidence of chronic Heart Failure (HF), which assumed epidemic proportions nowadays. Except for heart transplantation, all treatments for HF should be considered palliative because none of the current therapies can reverse myocardial degeneration responsible for HF syndrome. To stop the HF epidemic will ultimately require protocols to reduce the progressive cardiomyocyte (CM) loss and to foster their regeneration. It is now generally accepted that mammalian CMs renew throughout life. However, this endogenous regenerative reservoir is insufficient to repair the extensive damage produced by AMI/IHD while the source and degree of CM turnover remains strongly disputed. Independent groups have convincingly shown that the adult myocardium harbors bona-fide tissue specific cardiac stem cells (CSCs). Unfortunately, recent reports have challenged the identity and the endogenous myogenic capacity of the c-kit expressing CSCs. This has hampered progress and unless this conflict is settled, clinical tests of repair/regenerative protocols are unlikely to provide convincing answers about their clinical potential. Here we review recent data that have eventually clarified the specific phenotypic identity of true multipotent CSCs. These cells when coaxed by embryonic cardiac morphogens undergo a precisely orchestrated myogenic commitment process robustly generating bona-fide functional cardiomyocytes. These data should set the path for the revival of further investigation untangling the regenerative biology of adult CSCs to harness their potential for HF prevention and treatment.Funding Information
- Ministero dell’Istruzione, dell’Università e della Ricerca (PRIN2015 2015ZTT5KB_004)
- Ministero della Salute (inalized Research2010 (GR- 2010-2318945))
- Ministero dell’Istruzione, dell’Università e della Ricerca (PON03PE_00009_2—iCARE)
- Ministero dell’Istruzione, dell’Università e della Ricerca (FIRBFuturo- in-Ricerca (RBFR12I3KA))
This publication has 165 references indexed in Scilit:
- Coordinating Tissue Interactions: Notch Signaling in Cardiac Development and DiseaseDevelopmental Cell, 2012
- A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β-catenin signallingThe EMBO Journal, 2012
- Adult Cardiac-Resident MSC-like Stem Cells with a Proepicardial OriginCell Stem Cell, 2011
- Effects of Age and Heart Failure on Human Cardiac Stem Cell FunctionThe American Journal of Pathology, 2011
- Cell-based Therapy for Heart Disease: A Clinically Oriented PerspectiveMolecular Therapy, 2009
- Insights into the Characteristics of Mammalian Cardiomyocyte Terminal Differentiation Shown Through the Study of Mice with a Dysfunctional c-KitPediatric Cardiology, 2009
- Nkx2-5- and Isl1-expressing cardiac progenitors contribute to proepicardiumBiochemical and Biophysical Research Communications, 2008
- Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heartNature, 2008
- Telomerase and the aging processExperimental Gerontology, 2007
- Vagaries of conditional gene targetingNature Immunology, 2007